JOSEPH JANKOVIC to Research Design
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Research Design.
Connection Strength
0.327
-
How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson's disease? Expert Rev Neurother. 2023 02; 23(2):107-122.
Score: 0.145
-
Designing clinical trials for dystonia. Neurotherapeutics. 2014 Jan; 11(1):117-27.
Score: 0.077
-
Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord. 2007 Dec; 22(16):2371-7.
Score: 0.051
-
Evidence-based review of patient-reported outcomes with botulinum toxin type A. Clin Neuropharmacol. 2004 Sep-Oct; 27(5):234-44.
Score: 0.040
-
A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med. 2009 Sep 24; 361(13):1268-78.
Score: 0.014